[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)

Clinical trial NCT03724253 · TERMINATED

Trial details

NCT number: NCT03724253
Sponsor: Advanced Accelerator Applications
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Prostate Cancer Colorectal Cancer Non Small Cell Lung Cancer Small Cell Lung Cancer

Start date: 2018-07-03
Primary completion: 2019-06-20
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.